Next Biomedical Co.,Ltd. (KOSDAQ:389650)

Market Cap	225.14B -56.9%
Revenue (ttm)	17.79B +46.2%
Net Income	232.56M
EPS	28.41
Shares Out	8.28M
PE Ratio	957.39
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	23,247
Open	25,600
Previous Close	26,450
Day's Range	25,200 - 27,200
52-Week Range	25,150 - 101,000
Beta	-0.78
Analysts	Strong Buy
Price Target	87,666.67 (+222.3%)
Est. Earnings	Nov 13, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea.

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 2014
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 389650

Analyst Summary

According to 3 analysts, the average rating for 389650 stock is "Strong Buy." The 12-month stock price target is ₩87,667, which is an increase of 222.30% from the latest price.

Price Target

₩87,667

(222.30% upside)

Analyst Consensus: Strong Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 23, 2026

Data Sources Report a data error